423 related articles for article (PubMed ID: 19442151)
21. Estrogens in human vascular diseases.
Klouche M
Ann N Y Acad Sci; 2006 Nov; 1089():431-43. PubMed ID: 17261786
[TBL] [Abstract][Full Text] [Related]
22. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
Harman SM
Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
[TBL] [Abstract][Full Text] [Related]
23. Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Yue W; Berstein L
Endocr Relat Cancer; 2003 Jun; 10(2):111-30. PubMed ID: 12790774
[TBL] [Abstract][Full Text] [Related]
24. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Saha T; Makar S; Swetha R; Gutti G; Singh SK
Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
[TBL] [Abstract][Full Text] [Related]
25. Toxicology of environmental estrogens.
Safe SH; Pallaroni L; Yoon K; Gaido K; Ross S; Saville B; McDonnellc D
Reprod Fertil Dev; 2001; 13(4):307-15. PubMed ID: 11800169
[TBL] [Abstract][Full Text] [Related]
26. How sex hormones promote skeletal muscle regeneration.
Velders M; Diel P
Sports Med; 2013 Nov; 43(11):1089-100. PubMed ID: 23888432
[TBL] [Abstract][Full Text] [Related]
27. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
[TBL] [Abstract][Full Text] [Related]
28. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.
Iorga A; Cunningham CM; Moazeni S; Ruffenach G; Umar S; Eghbali M
Biol Sex Differ; 2017 Oct; 8(1):33. PubMed ID: 29065927
[TBL] [Abstract][Full Text] [Related]
29. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Estrogen Receptor in Arterial and Lymphatic Vascular Diseases.
Fontaine C; Morfoisse F; Tatin F; Zamora A; Zahreddine R; Henrion D; Arnal JF; Lenfant F; Garmy-Susini B
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375307
[TBL] [Abstract][Full Text] [Related]
31. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery.
Patkar S; Farr TD; Cooper E; Dowell FJ; Carswell HV
Neurosci Res; 2011 Sep; 71(1):78-84. PubMed ID: 21624404
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
F1000Res; 2019; 8():. PubMed ID: 31543950
[TBL] [Abstract][Full Text] [Related]
33. Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
Lecomte S; Demay F; Ferrière F; Pakdel F
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28657580
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.
Nakamura Y; Suzuki T; Miki Y; Tazawa C; Senzaki K; Moriya T; Saito H; Ishibashi T; Takahashi S; Yamada S; Sasano H
Mol Cell Endocrinol; 2004 Apr; 219(1-2):17-26. PubMed ID: 15149723
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptors as targets for drug development for breast cancer, osteoporosis and cardiovascular diseases.
Thomas T; Gallo MA; Thomas TJ
Curr Cancer Drug Targets; 2004 Sep; 4(6):483-99. PubMed ID: 15379634
[TBL] [Abstract][Full Text] [Related]
36. Licorice root components in dietary supplements are selective estrogen receptor modulators with a spectrum of estrogenic and anti-estrogenic activities.
Boonmuen N; Gong P; Ali Z; Chittiboyina AG; Khan I; Doerge DR; Helferich WG; Carlson KE; Martin T; Piyachaturawat P; Katzenellenbogen JA; Katzenellenbogen BS
Steroids; 2016 Jan; 105():42-9. PubMed ID: 26631549
[TBL] [Abstract][Full Text] [Related]
37. The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.
Menazza S; Murphy E
Circ Res; 2016 Mar; 118(6):994-1007. PubMed ID: 26838792
[TBL] [Abstract][Full Text] [Related]
38. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.
Albini A; Rosano C; Angelini G; Amaro A; Esposito AI; Maramotti S; Noonan DM; Pfeffer U
Curr Med Chem; 2014; 21(9):1129-45. PubMed ID: 24304271
[TBL] [Abstract][Full Text] [Related]
39. Activation of estrogen receptor alpha and ERbeta by 4-methylbenzylidene-camphor in human and rat cells: comparison with phyto- and xenoestrogens.
Mueller SO; Kling M; Arifin Firzani P; Mecky A; Duranti E; Shields-Botella J; Delansorne R; Broschard T; Kramer PJ
Toxicol Lett; 2003 Apr; 142(1-2):89-101. PubMed ID: 12765243
[TBL] [Abstract][Full Text] [Related]
40. β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia.
Meng Q; Li J; Chao Y; Bi Y; Zhang W; Zhang Y; Ji T; Fu Y; Chen Q; Zhang Q; Li Y; Bian H
Biochem Pharmacol; 2020 Oct; 180():114134. PubMed ID: 32628929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]